B

Bio-Rad Laboratories IncClass A
D

BIO

356.20
USD
2.18
(0.62%)
Market Open
Volume
4,971
EPS
11
Div Yield
-
P/E
-13
Market Cap
9,972,447,693
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    -0.45
    (-0.16%)
    274.31 USD
    BIIB
    BIIB
    2.120
    (1.50%)
    143.060 USD
    B
    BMRN
    -0.520
    (-0.83%)
    61.970 USD
    GILD
    GILD
    0.260
    (0.28%)
    93.210 USD
    I
    ICUI
    -0.390
    (-0.23%)
    166.640 USD
    ILMN
    ILMN
    -0.645
    (-0.46%)
    140.660 USD
    I
    INCY
    -0.700
    (-0.95%)
    72.770 USD
    M
    MASI
    -1.477
    (-0.84%)
    174.850 USD
    REGN
    REGN
    -1.77
    (-0.26%)
    685.55 USD
    VRTX
    VRTX
    2.55
    (0.60%)
    430.23 USD
    More
News

Title: Bio/Rad Laboratories IncClass A

Sector: Healthcare
Industry: Medical Devices
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.